NCT06888193 A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) Status RECRUITING Phase PHASE1
NCT06840392 A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa Status RECRUITING Phase PHASE3
NCT06799000 A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06785675 Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06768671 An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06707246 A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients Status RECRUITING Phase NA
NCT06685835 A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06603077 A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT06599411 Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases Status NOT_YET_RECRUITING Phase N/A
NCT06568224 Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis Status COMPLETED Phase N/A
NCT06555328 Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa Status TERMINATED Phase PHASE2
NCT06524635 A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab Status RECRUITING Phase PHASE2
NCT06517732 Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06468228 A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Status RECRUITING Phase PHASE3
NCT06444087 Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06411899 A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06411379 Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Status ACTIVE_NOT_RECRUITING Phase PHASE3